Nanobac Pharmaceuticals Accounts Payable

Nanobac Pharmaceuticals (NNBP) currently reports a accounts payable of $1.1M as of December 2007. That compares with $410K in the prior-year period — up 163.9% year over year. Use the charts on this page to explore Nanobac Pharmaceuticals's accounts payable history and peer comparisons.

Nanobac Pharmaceuticals's accounts payable increased from $410K to $1.1M — a 163.9% year-over-year increase (period ending December 2007). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Nanobac Pharmaceuticals reported $1.1M in accounts payable as of December 2007. That compares with $410K in the prior-year period — up 163.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $1.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Nanobac Pharmaceuticals, and consider following NNBP for alerts when major investors trade the stock.

Nanobac Pharmaceuticals is classified in the Healthcare sector. On accounts payable, it currently shows $1.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NNBP with unrelated industries.